Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. (Q43416268)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 August 2013

edit

Language	Label	Description	Also known as
English	Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.	scientific article published on 11 August 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

title

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

main subject

granulomatosis with polyangiitis

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

author

Emilio Besada

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

Johannes C Nossent

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

author name string

Wenche Koldingsnes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

publication date

11 August 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

published in

Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

volume

52

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

page(s)

2041-2047

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

cites work

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Etanercept plus standard therapy for Wegener's granulomatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Complications of long-term therapy for ANCA-associated systemic vasculitis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Does rituximab increase the incidence of infectious complications? A narrative review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Serum immunoglobulins and risk of infection: how low can you go?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET257

retrieved

21 January 2018

Identifiers

DOI

10.1093/RHEUMATOLOGY/KET257

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

PubMed publication ID

23934313

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23934313

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934313%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 March 2020

ResearchGate publication ID

255735512

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43416268&oldid=1611614667"